Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

nVNS, CBD, and SoC for Persistent Post-Traumatic Headache

NCT: NCT07624279 · NOT_YET_RECRUITING

NCT IDNCT07624279
StatusNOT_YET_RECRUITING
Start Date2026-06-01
Completion2028-07-01
SponsorAmerican Society of Pain and Neuroscience, Inc. (OTHER)
First posted
Last updated

Brief Summary

Do cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑